Xtandi 80 MG Oral Tablet

RxCUI
2390650
RxNorm name
Xtandi 80 MG Oral Tablet
Display name
Xtandi 80 MG Oral Tablet
Full name
Xtandi 80 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XtandiENZALUTAMIDEAstellas Pharma US, Inc.b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf2026-05-26Warnings, Adverse reactionsExact identifier
rxcui: 2390650

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdfXtandi 80 MG Oral TabletSY22These highlights do not include all the information needed to use XTANDI safely and effectively. See full prescribing information for XTANDI. XTANDI ® (enzalutamide) capsules, for oral use XTANDI ® (enzalutamide) tablets, for oral use Initial U.S. Approval: 201220251212
b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdfXtandi 80 MG Oral TabletPSN22These highlights do not include all the information needed to use XTANDI safely and effectively. See full prescribing information for XTANDI. XTANDI ® (enzalutamide) capsules, for oral use XTANDI ® (enzalutamide) tablets, for oral use Initial U.S. Approval: 201220251212
b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdfenzalutamide 80 MG Oral Tablet [Xtandi]SBD22These highlights do not include all the information needed to use XTANDI safely and effectively. See full prescribing information for XTANDI. XTANDI ® (enzalutamide) capsules, for oral use XTANDI ® (enzalutamide) tablets, for oral use Initial U.S. Approval: 201220251212